PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities. 2010

Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. mmbikay@ohri.ca

Proprotein convertase subtilisin/kexin type 9 (PCSK9), a liver-secreted plasma enzyme, restricts hepatic uptake of low-density lipoprotein (LDL) cholesterol by promoting the degradation of LDL receptors (LDLR). PCSK9 and LDLR are also expressed in insulin-producing pancreatic islet beta cells, possibly affecting the function of these cells. Here we show that, compared to control mice, PCSK9-null male mice over 4 months of age carried more LDLR and less insulin in their pancreas; they were hypoinsulinemic, hyperglycemic and glucose-intolerant; their islets exhibited signs of malformation, apoptosis and inflammation. Collectively, these observations suggest that PCSK9 may be necessary for the normal function of pancreatic islets.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D000071449 Proprotein Convertase 9 A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS. NARC-1 Protein,Neural Apoptosis-Regulated Convertase 1,Proprotein Convertase, Subtilisin-Kexin Type 9,Convertase 9, Proprotein,NARC 1 Protein,Neural Apoptosis Regulated Convertase 1,Proprotein Convertase, Subtilisin Kexin Type 9

Related Publications

Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
July 2015, Endocrinology,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
July 2002, Diabetologia,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
December 1997, Metabolism: clinical and experimental,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
May 2000, The Journal of clinical investigation,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
June 2020, Endocrinology and metabolism (Seoul, Korea),
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
May 1983, The Journal of nutrition,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
September 1997, Immunology,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
December 2022, Advances in redox research,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
August 2004, European journal of pharmacology,
Majambu Mbikay, and Francine Sirois, and Janice Mayne, and Gen-Sheng Wang, and Andrew Chen, and Thilina Dewpura, and Annik Prat, and Nabil G Seidah, and Michel Chretien, and Fraser W Scott
April 1996, Metabolism: clinical and experimental,
Copied contents to your clipboard!